Published in J Pharmacol Exp Ther on September 01, 1999
Prostaglandin F2(alpha) stimulates growth of skeletal muscle cells via an NFATC2-dependent pathway. J Cell Biol (2003) 1.46
Prostaglandin E2 mediates cough via the EP3 receptor: implications for future disease therapy. Am J Respir Crit Care Med (2009) 1.43
Prostanoid receptor antagonists: development strategies and therapeutic applications. Br J Pharmacol (2009) 1.31
Prostaglandin F(2alpha) receptor signaling facilitates bleomycin-induced pulmonary fibrosis independently of transforming growth factor-beta. Nat Med (2009) 1.28
Prostamides (prostaglandin-ethanolamides) and their pharmacology. Br J Pharmacol (2007) 1.23
A novel angiogenic role for prostaglandin F2alpha-FP receptor interaction in human endometrial adenocarcinomas. Cancer Res (2005) 1.20
Suppression of adipocyte differentiation by aldo-keto reductase 1B3 acting as prostaglandin F2alpha synthase. J Biol Chem (2010) 1.04
Prostaglandin F(2alpha)-F-prostanoid receptor regulates CXCL8 expression in endometrial adenocarcinoma cells via the calcium-calcineurin-NFAT pathway. Biochim Biophys Acta (2009) 1.01
Identification of an antagonist that selectively blocks the activity of prostamides (prostaglandin-ethanolamides) in the feline iris. Br J Pharmacol (2006) 0.99
Discovery of prostamide F2α and its role in inflammatory pain and dorsal horn nociceptive neuron hyperexcitability. PLoS One (2012) 0.98
Prostaglandin E2 and F2alpha activate the FP receptor and up-regulate cyclooxygenase-2 expression via the cyclic AMP response element. Mol Cell Endocrinol (2008) 0.94
Dissecting fibrosis: therapeutic insights from the small-molecule toolbox. Nat Rev Drug Discov (2015) 0.93
F-prostanoid receptor alters adhesion, morphology and migration of endometrial adenocarcinoma cells. Oncogene (2007) 0.90
Role of contractile prostaglandins and Rho-kinase in growth factor-induced airway smooth muscle contraction. Respir Res (2005) 0.88
Prostaglandin F2α FP receptor antagonist improves outcomes after experimental traumatic brain injury. J Neuroinflammation (2013) 0.88
Mechanisms involved in PGE2-induced transactivation of the epidermal growth factor receptor in MH1C1 hepatocarcinoma cells. J Exp Clin Cancer Res (2012) 0.88
Insulin induces airway smooth muscle contraction. Br J Pharmacol (2006) 0.84
Characterising the mechanism of airway smooth muscle β2 adrenoceptor desensitization by rhinovirus infected bronchial epithelial cells. PLoS One (2013) 0.82
Effects of progesterone on motility and prostaglandin levels in the distal guinea pig colon. Am J Physiol Gastrointest Liver Physiol (2009) 0.82
Effects of prostaglandin analogues on aqueous humor outflow pathways. J Ocul Pharmacol Ther (2013) 0.81
Dysregulated post-transcriptional control of COX-2 gene expression in gestational diabetic endothelial cells. Br J Pharmacol (2015) 0.80
Pharmacological characterization of prostanoid receptors mediating vasoconstriction in human umbilical vein. Br J Pharmacol (2003) 0.80
Cyclic AMP-mediated chloride secretion is induced by prostaglandin F2alpha in human isolated colon. Br J Pharmacol (2009) 0.79
A unique mechanism of successful fertilization in a domestic bird. Sci Rep (2015) 0.78
PG F(2α) Receptor: A Promising Therapeutic Target for Cardiovascular Disease. Front Pharmacol (2010) 0.76
Ocular hypotensive FP prostaglandin (PG) analogs: PG receptor subtype binding affinities and selectivities, and agonist potencies at FP and other PG receptors in cultured cells. J Ocul Pharmacol Ther (2003) 1.30
Immortalized human corneal epithelial cells for ocular toxicity and inflammation studies. Invest Ophthalmol Vis Sci (1999) 1.18
The pharmacological properties of the peptide, endothelin. Br J Pharmacol (1989) 1.12
Inhibition of histamine-induced human conjunctival epithelial cell responses by ocular allergy drugs. Arch Ophthalmol (1999) 1.04
Pharmacological characterization of an FP prostaglandin receptor on rat vascular smooth muscle cells (A7r5) coupled to phosphoinositide turnover and intracellular calcium mobilization. J Pharmacol Exp Ther (1998) 0.98
PD117302: a selective agonist for the kappa-opioid receptor. Br J Pharmacol (1988) 0.96
Pharmacological characterization of [(3)H]-prostaglandin E(2) binding to the cloned human EP(4) prostanoid receptor. Br J Pharmacol (2000) 0.96
Functional evidence equating the pharmacologically-defined alpha 1A- and cloned alpha 1C-adrenoceptor: studies in the isolated perfused kidney of rat. Br J Pharmacol (1995) 0.95
Pharmacology of [3H]prostaglandin E1/[3H]prostaglandin E2 and [3H]prostaglandin F2alpha binding to EP3 and FP prostaglandin receptor binding sites in bovine corpus luteum: characterization and correlation with functional data. J Pharmacol Exp Ther (1998) 0.94
Preclinical efficacy of travoprost, a potent and selective FP prostaglandin receptor agonist. J Ocul Pharmacol Ther (2001) 0.93
Prostaglandin DP receptors positively coupled to adenylyl cyclase in embryonic bovine tracheal (EBTr) cells: pharmacological characterization using agonists and antagonists. Br J Pharmacol (1999) 0.93
Rho-Rho kinase pathway in the actomyosin contraction and cell-matrix adhesion in immortalized human trabecular meshwork cells. Mol Vis (2011) 0.92
Topical formulations of novel angiostatic steroids inhibit rabbit corneal neovascularization. Invest Ophthalmol Vis Sci (1997) 0.89
Quantitative autoradiographic visualization and pharmacology of FP-prostaglandin receptors in human eyes using the novel phosphor-imaging technology. J Ocul Pharmacol Ther (1999) 0.89
Agonist activity of bimatoprost, travoprost, latanoprost, unoprostone isopropyl ester and other prostaglandin analogs at the cloned human ciliary body FP prostaglandin receptor. J Ocul Pharmacol Ther (2002) 0.88
Comparative effects of topical ocular anti-allergy drugs on human conjunctival mast cells. Ann Allergy Asthma Immunol (1997) 0.87
Dopamine D2-receptors mediate hypothermia in mice: ICV and IP effects of agonists and antagonists. Neurochem Res (1991) 0.87
Endogenous EP4 prostaglandin receptors coupled positively to adenylyl cyclase in Chinese hamster ovary cells: pharmacological characterization. Prostaglandins Leukot Essent Fatty Acids (2000) 0.87
Phospholipid turnover during cell-cycle traverse in synchronous Chinese-hamster ovary cells. Mitogenesis without phosphoinositide breakdown. Biochem J (1988) 0.86
Effects of l-glutamate and related amino acids upon the release of [3H]dopamine from rat striatal slices. Brain Res (1978) 0.86
FP prostaglandin receptors mediating inositol phosphates generation and calcium mobilization in Swiss 3T3 cells: a pharmacological study. J Pharmacol Exp Ther (1997) 0.86
Characterization and autoradiographic localization of TRH receptors in sections of rat brain. Brain Res (1984) 0.84
Benzodiazepines compete for thyrotropin-releasing hormone receptor binding: micromolar potency in rat pituitary, retina and amygdala. Neurosci Lett (1983) 0.84
Problems associated with the binding of L-glutamic acid to synaptic membranes: methodological aspects. J Neurochem (1980) 0.82
Codepletion of serotonin and TRH induces apparent supersensitivity of spinal TRH receptors. Eur J Pharmacol (1983) 0.81
Effects of bradykinin on signal transduction, cell proliferation, and cytokine, prostaglandin E2 and collagenase-1 release from human corneal epithelial cells. Br J Pharmacol (1998) 0.81
Rat brain TRH receptors: kinetics, pharmacology, distribution and ionic effects. Regul Pept (1983) 0.81
Levobetaxolol (Betaxon) and other beta-adrenergic antagonists: preclinical pharmacology, IOP-lowering activity and sites of action in human eyes. J Ocul Pharmacol Ther (2001) 0.80
Striatal glutamatergic function: modifications following specific lesions. Brain Res (1982) 0.80
Sulfhydryl groups in receptor binding of thyrotropin-releasing hormone to rat amygdala. J Neurochem (1984) 0.80
Muscarinic M3 receptors mediate total inositol phosphates accumulation in murine HSDM1C1 fibrosarcoma cells. Eur J Pharmacol (1993) 0.80
Characteristics of [3H]5-hydroxytryptamine binding to iris-ciliary body tissue of the rabbit. Invest Ophthalmol Vis Sci (1995) 0.80
The effects of elevated glucose on Na+/K(+)-ATPase of cultured bovine retinal pigment epithelial cells measured by a new nonradioactive rubidium uptake assay. J Ocul Pharmacol Ther (1997) 0.79
The expression of functionally-coupled B2-bradykinin receptors in human corneal epithelial cells and their pharmacological characterization with agonists and antagonists. Br J Pharmacol (1997) 0.79
Affinities, selectivities, potencies, and intrinsic activities of natural and synthetic prostanoids using endogenous receptors: focus on DP class prostanoids. J Pharmacol Exp Ther (2000) 0.79
Use of a semi-automated, robotic radioimmunoassay to measure cAMP generated by activation of DP-, EP2-, and IP-prostaglandin receptors in human ocular and other cell types. Prostaglandins Leukot Essent Fatty Acids (1998) 0.79
Prostaglandin-stimulated adenylyl cyclase activity via a pharmacologically defined EP2 receptor in human nonpigmented ciliary epithelial cells. J Ocul Pharmacol Ther (1998) 0.79
Phosphonate analogues of acidic amino acids: inhibition of excitatory amino acid transmitter binding to cerebellar membranes and of the stimulation of cerebellar cyclic GMP levels. Brain Res (1982) 0.78
L-Aspartate binding sites in rat cerebellum: a comparison of the binding of L-[3H]aspartate and L-[3H]glutamate to synaptic membranes. Brain Res (1981) 0.78
Regulation of cerebellar L-[3H]glutamate binding: influence of guanine nucleotides and Na+ ions. Biochem Pharmacol (1981) 0.78
Pharmacological analysis of mast cell mediator and neurotransmitter receptors coupled to adenylate cyclase and phospholipase C on immunocytochemically-defined human conjunctival epithelial cells. J Ocul Pharmacol Ther (1997) 0.78
[(3)H]-serotonin release from bovine iris-ciliary body: pharmacology of prejunctional serotonin (5-HT(7)) autoreceptors. Exp Eye Res (2001) 0.77
Flow cytometric analysis of internal calcium mobilization via a B2-bradykinin receptor on a subclone of PC-12 cells. J Neurochem (1991) 0.77
Multiple synaptic receptors for neuroactive amino acid transmitters--new vistas. Int Rev Neurobiol (1985) 0.77
Hypoxia-induced [(3)H]D-aspartate release from isolated bovine retina: modulation by calcium-channel blockers and glutamatergic agonists and antagonists. Curr Eye Res (2001) 0.77
AL-3138 antagonizes FP prostanoid receptor-mediated inositol phosphates generation: comparison with some purported FP antagonists. J Pharm Pharmacol (2000) 0.77
Neurochemical, pharmacological, and developmental studies on cerebellar receptors for dicarboxylic amino acids. Neurochem Res (1984) 0.77
Micromolar substance P reduces spinal receptor binding for thyrotropin-releasing hormone--possible relevance to neuropeptide coexistence? Neurosci Lett (1983) 0.77
A current appreciation of sites for pharmacological intervention in allergic conjunctivitis: effects of new topical ocular drugs. Acta Ophthalmol Scand Suppl (1999) 0.76
Receptors for thyrotropin-releasing hormone (TRH) in rabbit spinal cord. Brain Res (1983) 0.76
Characterization of the m4 muscarinic receptor Ca2+ response in a subclone of PC-12 cells by single cell flow cytometry. Inhibition of the response by bradykinin. J Biol Chem (1991) 0.76
Biochemical similarity of rat pituitary and CNS TRH receptors. Neurosci Lett (1983) 0.76
Modulation of receptors for thyrotropin-releasing hormone by benzodiazepines: brain regional differences. J Neurochem (1984) 0.76
Thyrotropin-releasing hormone gene expression and receptors are differentially modified in limbic foci by seizures. Ann Neurol (1993) 0.76
Bimatoprost, the prodrug of a prostaglandin analogue. Br J Ophthalmol (2008) 0.75
AT1 angiotensin receptors mobilize intracellular calcium in a subclone of NG108-15 neuroblastoma cells. J Neurochem (1992) 0.75
Radioreceptor binding studies with glutamate and aspartate. Adv Biochem Psychopharmacol (1981) 0.75
Effects of protein- and membrane-modifying agents on the binding of L-[3H]glutamate to cerebellar synaptic membranes. Brain Res (1980) 0.75
Binding of L-[3H]glutamate to cerebellar synaptic membranes: stability of receptor sites and effects of protein- and membrane-modifying agents [proceedings]. Biochem Soc Trans (1980) 0.75
Effect of guanine nucleotides on binding of L-3H-glutamate to cerebellar synaptic membranes. Eur J Pharmacol (1980) 0.75
Human, bovine, and rabbit retinal glutamate-induced [3H]D-aspartate release: role in excitotoxicity. Neurochem Res (2000) 0.75
Effects of naphthalene on the hemoglobin concentration and oxygen uptake of Daphnia magna. Bull Environ Contam Toxicol (1982) 0.75
Biochemical and autoradiographic studies of TRH receptors in sections of rabbit spinal cord. Biochem Biophys Res Commun (1983) 0.75
A new chromatographic method for measurement of rubidium transport activities in cultured bovine retinal pigment epithelial cells. Ophthalmic Res (1997) 0.75
Pharmacology of functional endogenous IP prostanoid receptors in NCB-20 cells: comparison with binding data from human platelets. Prostaglandins Leukot Essent Fatty Acids (2002) 0.75
1-[2-methoxy-5-(3-phenylpropyl)]-2-aminopropane unexpectedly shows 5-HT(2A) serotonin receptor affinity and antagonist character. J Med Chem (2001) 0.75
Functional pharmacological evidence for EP2 and EP4 prostanoid receptors in immortalized human trabecular meshwork and non-pigmented ciliary epithelial cells. J Ocul Pharmacol Ther (2001) 0.75
Synthesis and biological activity of a novel 11a-homo (cyclohexyl) prostaglandin. J Med Chem (2000) 0.75
Levobetaxolol (Betaxon): in vitro pharmacology, intraocular pressure lowering activity and autoradiographic localization of beta-adrenoceptors in human eyes. Proc West Pharmacol Soc (2001) 0.75
Limbic, hypothalamic, cortical and spinal regions are enriched in receptors for thyrotropin-releasing hormone: evidence from [3H]ultrofilm autoradiography and correlation with central effects of the tripeptide in rat brain. Neurosci Lett (1985) 0.75